Skip to main content
. Author manuscript; available in PMC: 2013 Feb 2.
Published in final edited form as: Mol Pharm. 2011 Aug 9;8(5):1652–1661. doi: 10.1021/mp100464y

Figure 1.

Figure 1

CpG ODN enhances and chitosan reduces in vivo tumor protection and survival generated by adenovirus cancer vaccines. C57BL/6 mice were challenged subcutaneously with E.G7-OVA (upper two panels) or parental EL4 (bottom panel) tumor cells 14 days after adenovirus immunization. (a) Tumor volume and (b,c) percent survival were determined over time. Means ± SEM are shown and numbers in parentheses (upper panel) indicate tumor incidence.